电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant PDCD1 (Pembrolizumab Biosimilar) 抗体

Research Grade 适用: 人 ELISA 宿主: Mammalian Cells Monoclonal unconjugated Recombinant Antibody
产品编号 ABIN7487773
发货至: 中国
  • 抗原 See all PDCD1 (Pembrolizumab Biosimilar) products
    PDCD1 (Pembrolizumab Biosimilar)
    抗体类型
    Recombinant Antibody
    适用
    宿主
    • 1
    • 1
    Mammalian Cells
    Expression System
    Mammalian cells
    克隆类型
    • 2
    单克隆
    标记
    • 2
    This PDCD1 (Pembrolizumab Biosimilar) antibody is un-conjugated
    应用范围
    • 2
    • 1
    • 1
    ELISA
    原理
    Pembrolizumab Biosimilar - Anti-PD1 mAb
    产品特性
    Antibody Type: IgG4
    纯化方法
    Recombinant antibody expressed in mammalien cells and purified.
    质量等级
    Research Grade
    亚型
    IgG4
  • 限制
    仅限研究用
  • 缓冲液
    PBS pH 7.5
    储存条件
    4 °C,-20 °C
    储存方法
    4°C for short term, -20°C for long term
  • 抗原
    PDCD1 (Pembrolizumab Biosimilar)
    Abstract
    PDCD1 (Pembrolizumab Biosimilar) 产品
    物质类
    Biosimilar
    背景
    Pembrolizumab
    Pembrolizumab is a humanized (from mouse) monoclonal antibody that binds to, and blocks PD-1 located on lymphocytes. It is an anticancer medication used in the treatment of melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, urothelial cancer (cancer of the bladder and urinary tract) and renal cell carcinoma (kidney cancer).
You are here:
客服